Anti-IL-6 antibodies, compositions, methods and uses
US7955597B2 · kind B2 · utility
63Cited by
26References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 2009 |
| Grant date | Jun 7, 2011 |
| Priority date | — |
| Expiry date | Jul 23, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to at least one novel chimeric, humanized or CDR-grafted anti-IL-6 antibodies derived from the murine CLB-8 antibody, including isolated nucleic acids that encode at least one such anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.